From the Journals
From the Journals
Early cryoprecipitate fails to improve trauma hemorrhage outcomes
It is possible that certain patients may have benefited from cryoprecipitate, but they did not receive it promptly or in adequate doses to restore...
Latest News
Black men are at higher risk of prostate cancer at younger ages, lower PSA levels
A large Veterans Affairs study finds that Black men with a prebiopsy PSA level of 4.0 ng/mL had the same risk of prostate cancer as White men with...
From the Journals
ADC with radiotherapy for brain mets ups risk of necrosis
“Clinicians should be cognizant of the [symptomatic radiation necrosis] risk and monitor patients closely when treating concurrently with ADCs.”...
Latest News
Can thermal biofeedback reduce pain and anxiety?
Device reduced anxiety scores by 22% in small study.
From the Journals
This tool can predict recurrence in rectal cancer watchful waiting
This validation study confirms that the Immunoscore biopsy “is an independent parameter predicting time to recurrence” and can help physicians and...
Latest News
ACS expands lung cancer screening eligibility
Greater uptake and adherence needed to reduce deaths.
From the Journals
Does diabetes affect colorectal cancer outcomes?
“Preventing diabetes complications may help improve survival in patients with CRC, especially [in] female patients and those in the early stages...
Latest News
Experts question finding that 70% cancer deaths are preventable
The findings represent a snapshot of premature mortality in 2020 but do not necessarily predict progress in cancer control over time.
Latest News
Study reveals potentially unnecessary CRC screening in older adults
“Personalized screening incorporating individual life expectancy may improve the value of screening.”
Latest News
Active surveillance preferred in low-risk prostate cancer
There was no difference in outcomes between treatment and active surveillance.
From the Journals
Doublet therapy ups survival in metastatic prostate cancer
“A clinically meaningful increase in long-term survival was observed in men diagnosed with de novo [metastatic castration-sensitive prostate...